Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Enveric Biosciences Inc ENVB

Healthcare
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety and addiction disorders. The Company, through Psybrary has created a robust intellectual property (IP) portfolio of new chemical entities for specific mental health indications. Its lead program, the EVM201... see more

NDAQ:ENVB - Post Discussion

Enveric Biosciences Inc > Enveric Biosciences Pursuing Exclusive Out-Licensing of Thre
View:
Post by whytestocks on Feb 29, 2024 11:30am

Enveric Biosciences Pursuing Exclusive Out-Licensing of Thre

NEWS: $ENVB Enveric Biosciences Pursuing Exclusive Out-Licensing of Three Classes of Compounds2024-02-29 07:32:31 ET DENVER, Colo., Feb 29, 2024 ( 247marketnews.com )- Enveric Biosciences (NASDAQ: ENVB ) stated, this morning, that it signed three non-binding term sheets to pursue the out-licensing of three classes of compounds, with an undisclosed company. Enveric is tra...ENVB - Enveric Biosciences Pursuing Exclusive Out-Licensing of Three Classes of Compounds
Be the first to comment on this post
Enveric Biosciences Inc